Treat-and-Extend Versus Pro re nata Regimens of Ranibizumab and Aflibercept in Neovascular Age-Related Macular Degeneration: A Comparative Study from Routine Clinical Practice

Abstract Introduction Anti-vascular endothelial growth factor (VEGF) is generally given using pro re nata or “treat-and-extend” (T&E) regimens for neovascular age-related macular degeneration (nAMD). Randomized clinical trials have reported that T&E is superior to Pro re nata (PRN), but results from...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Eloi Debourdeau, Helene Beylerian, Vuong Nguyen, Daniel Barthelmes, Mark Gillies, Pierre Henry Gabrielle, Stela Vujosevic, Louise Otoole, Martin Puzo, Catherine Creuzot-Garcher, Benjamin Wolff, Vincent Daien, The Fight Retinal Blindness! Study Group
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Adis, Springer Healthcare 2024-07-01
סדרה:	Ophthalmology and Therapy
נושאים:	Neovascular AMD Treat-and-extend Pro re nata Intraocular injection
גישה מקוונת:	https://doi.org/10.1007/s40123-024-00983-2
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!